MichaelLyonsDO

Chief Medical Officer

Dr. Lyons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of Texas Medical Branch HospitalsResidency, Family Medicine, 1992 - 1995
Texas College of Osteopathic MedicineClass of 1992
OtherClass of 1992
Southwest Texas State UniversityBS, Biology and Chemistry, 1980 - 1984

UTMB Family Medicine Clerkship (2010-2012)
Patient, Physician and Society Preceptor Baylor College of Medicine (2005-present)
G.W. Thompson Scholarship (1991-1992)
Sigma Sigma Phi Osteopathic Honors Fraternity (1989-present)
Houston Osteopathic Foundation Scholarship (1988-1992)
Teacher of Distinction Award UTMB School of Medicine, 2011
Dean’s Fellowship in Physiology 1989
Join now to see all

PubMed

Factors associated with adverse outcomes in patients with traumatic intracranial hemorrhage and Glasgow Coma Scale of 15.
Kreitzer, N.,Hart, K.,Lindsell, C. J.,Betham, B.,Gozal, Y.,Andaluz, N. O.,Lyons, M. S.,Bonomo, J.,Adeoye, O.> ;Am J Emerg Med. 2017 Feb 02

Lectures

Beyond the Statin Quo: The Role of Trilipix.
Diabetes and Lipids in the Modern Era: Crossroads of Two Cardiovascular Risk Equivalents.
Treating the Older, More Challenging Patient with Stage 2 Hypertension.
Reaching Aggressive LDL and A1C Goals: A Significant Treatment Challenge.
Reaching Aggressive LDL and A1C Goals: A Significant Treatment Challenge.
Welchol Pivotal Trails for Type 2 Diabetes: Reviewing the Study Design.
Nationally Recognized Guidelines from ADA and ACA / AACE for Managing Patients with Type 2 Diabetes.
Excellence in Lipid Management.
Role of Omacor in Treatment of Hypertriglyceridemia.
New Directions in the Management of Community – Acquired Lower Respiratory Infections: Clinical Exploration and Discussion.
PPAR Alpha Agonist in the Management of Artherogenic Dyslipidemia.
Balancing Clinical Efficacy with Antibiotic Resistance in your Practice.
Rational Selection of Abortive and Rescue Agents in Migraine Therapy.
An Innovative Treatment Technology in Treatment of Hypertension.
Risk Triggers and New Practice Patterns of CAD Prevention.
Join now to see all